| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3847970 | American Journal of Kidney Diseases | 2014 | 8 Pages |
Abstract
eGFRÂ <Â 60 mL/min/1.73Â m2 appears to be a significant risk factor for death from cancer. These effects appear to be site specific, with breast and urinary tract cancers incurring the greatest risk of death among those with reduced kidney function.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Samuel MD, Jonathan C. MD, PhD, Robin PhD, Jeremy R. MD, PhD, Jie J. MD, PhD, Paul MD, PhD, Germaine MD, PhD,